These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1287138)

  • 1. The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis.
    De Abate CA; Perrotta RJ; Dennington ML; Ziering RM
    J Chemother; 1992 Dec; 4(6):358-63. PubMed ID: 1287138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
    Gwaltney JM; Savolainen S; Rivas P; Schenk P; Scheld WM; Sydnor A; Keyserling C; Leigh A; Tack KJ
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1517-20. PubMed ID: 9210677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.
    Aubier MA
    Chemotherapy; 1997; 43(4):297-302. PubMed ID: 9209787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
    Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
    Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis.
    Sterkers O
    Chemotherapy; 1997; 43(5):352-7. PubMed ID: 9309369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
    Gris P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.
    Camacho AE; Cobo R; Otte J; Spector SL; Lerner CJ; Garrison NA; Miniti A; Mydlow PK; Giguere GC; Collins JJ
    Am J Med; 1992 Sep; 93(3):271-6. PubMed ID: 1524078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
    Biebuyck XA
    J Int Med Res; 1996; 24(5):407-18. PubMed ID: 8895044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulanate in the empiric treatment of acute otitis media. Members of the Ceftibuten Otitis Media United States Study Group.
    Mclinn SE; Mccarty JM; Perrotta R; Pichichero ME; Reidenberg BE
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S108-14. PubMed ID: 7567310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of loracarbef in the treatment of pneumonia.
    Hyslop DL
    Am J Med; 1992 Jun; 92(6A):65S-69S. PubMed ID: 1621747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women.
    Masterton RG; Bochsler JA
    J Antimicrob Chemother; 1995 Jan; 35(1):129-37. PubMed ID: 7768760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis.
    McAdoo MA; Rice K; Gordon GR; Sahn SA
    Clin Ther; 1998; 20(1):88-100. PubMed ID: 9522107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.
    Zachariah J
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():103-13. PubMed ID: 8818851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
    Edelstein DR; Avner SE; Chow JM; Duerksen RL; Johnson J; Ronis M; Rybak LP; Bierman WC; Matthews BL; Kohlbrenner VM
    Laryngoscope; 1993 Jan; 103(1 Pt 1):33-41. PubMed ID: 8421417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
    Hyslop DL; Jacobson K; Guerra FJ
    Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.
    Guest N; Langan CE
    Int J Antimicrob Agents; 1998 Apr; 10(1):49-54. PubMed ID: 9624543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative efficacy and safety of amoxiclav (amoxicillin clavulanate) and ampicillin in the treatment of acute bacterial sinusitis].
    Kriukov AI; Sedinkin AA
    Vestn Otorinolaringol; 2004; (1):49-50. PubMed ID: 15029125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.